Vectura appoints Neil Warner non-executive director and chair of audit committee
This article was originally published in Scrip
Vectura Group, a UK-based company developing inhaled therapies for the treatment of respiratory diseases, has elected Neil Warner non-executive director and chair of the audit committee, effective 1 February. Mr Warner replaces Dr John Brown as chair of the audit committee; he will remain as Vectura's senior independent director and chair of the nomination committee. Mr Warner was finance director of Chloride Group for almost 14 years, and is the senior independent director and chair of the audit committee of Dechra Pharmaceuticals.